|
In March, CIGNA released policy 0539, characterizing peripheral nerve stimulation (PNS) as “not medically necessary.” NANS is currently working with the PNS Subcommittee to respond to this categorization.
1 Comment
NANS joins the Multisociety Pain Workgroup to object to Palmetto’s draft local coverage determination (LCD DL39797) for minimally invasive arthrodesis of the sacroiliac joint. Palmetto is Medicare Administrative Contractor (MAC) with jurisdiction over several states in the Southeast U.S.
In December, NANS led efforts on behalf of the Multisociety Pain Workgroup (MPW) to object to the insurers’ classification of closed-loop spinal cord stimulation (SCS) as “experimental, investigational and/or unproven.” Thanks to these efforts, Cigna and EviCore (and includes several Blue Cross Blue Shield plans) have revised their policies to include coverage of closed-loop SCS. These revised policies become effective May 1, 2024.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
August 2024
Categories |
RSS Feed